Advancement of autoimmune program demonstrates continued success of Schrödinger computational platform for drug discovery NEW YORK – Schrödinger today announced receipt of a milestone payment from Sanofi (EURONEXT: SAN, NASDAQ: SNY) to mark the advancement into the clinic of an autoimmune therapy discovered as part of a multi-year, multi-target collaboration between the two companies. Under the […]
NEW YORK – Schrödinger today announced the appointment of Professor of Chemistry, Brian Shoichet, Ph.D., a widely published thought leader in the field of computational drug discovery, to its scientific advisory board (SAB). Schrödinger is a privately held company revolutionizing drug discovery and materials design through advanced molecular simulations. “I am thrilled to join the exceptional team […]
Collaboration enables drug discovery researchers to generate alternative, novel synthesis pathways for target molecules Partnership expands number of free extensions available through StarDrop CAMBRIDGE, UK and MUNICH, GERMANY – Optibrium™, a developer of software for drug discovery, today announced a collaboration with InfoChem GmbH, a leader in cheminformatics. The collaboration provides StarDrop™ users with easy access […]
CAMBRIDGE, UNITED KINGDOM – Optibrium, a developer of software for drug discovery, today announced a collaboration with InfoChem GmbH, a leader in cheminformatics. The collaboration provides StarDrop users with easy access to ICSYNTH light, an entry-level version of InfoChems computer-aided synthesis design (CASD) software to generate synthesis pathways for a target molecule. By stimulating new and […]
Big Data project will create comprehensive database of chemistry and bioactivity related content to help increase the visibility, reusability and actionability of existing information New York Elsevier, the information analytics business specializing in science and health, announced today that Lundbeck, the global pharmaceutical company specializing in brain diseases has selected Elsevier’s Reaxys and Reaxys Medicinal Chemistry […]
We are pleased to announce Schrödinger software release 2019-1, which is available for download now. This quarterly release includes usability improvements and performance enhancements across all of our software. Click here to learn more about new features in 2019-1. CLOSE
NEW YORK – Schrödinger, a privately held company revolutionizing drug discovery and materials design through advanced molecular simulations, today announced the appointment of veteran biotech leader Rosana Kapeller, M.D., Ph.D., to its board of directors. “I am delighted and honored to join Schrödinger during such a pivotal time in the company’s growth,” said Dr. Kapeller. […]
Scilligence Joins Accenture’s Life Sciences Research Platform Ecosystem to Help Drive Innovation in Drug Discovery and Scientific Research BOSTON: Scilligence, a provider of mobile cheminformatics and bioinformatics for the life sciences industry, has joined the Accenture research platform open partner ecosystem, which will allow for the integration of Scilligence’s informatics solutions. Scilligence’s proprietary technologies address three […]
Stuttgart – Known for providing high-quality chemical information in the field of organic synthesis, Thieme Chemistry has provided approximately 700,000 distinct structures to PubChem – the open chemistry database at the National Institutes of Health (NIH). In addition to the structural information, the upload includes more than 1,200,000 distinct links from chemicals to the Thieme Chemistry […]
Investment in R&D will extend capabilities of computational platform and support growth of partnered and proprietary programs NEW YORK – Schrödinger, a privately held company revolutionizing drug discovery through advanced molecular simulations, today announced the closing of an $85 million financing to support continued growth and innovation of its computational platform and expansion of its […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
